NCT00002033View on ClinicalTrials.gov

A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

DRUG

AS-101

Trial Locations (4)

Unknown

Escola Paulista De-Medicina, São Paulo

Faculdade De-Ciencias Medica Da, São Paulo

Hosp De-Servidor Publico Estadual, São Paulo

Instituto Do Cancer Arnaldo Vieiro, São Paulo

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00002033 - A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease | Biotech Hunter | Biotech Hunter